2012
DOI: 10.1016/j.remn.2011.04.009
|View full text |Cite
|
Sign up to set email alerts
|

PET-TAC con 18F-FDG en el seguimiento de pacientes con linfoma: detección de recidivas asintomáticas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 28 publications
0
2
0
Order By: Relevance
“…[1] Furthermore, it is a sensitive modality for early detection of relapse in asymptomatic patients making surveillance 18 F-FDG PET/CT clinically important. [2] Splenic uptake on 18 F-FDG PET can be due to a wide variety of causes such as lymphoma, anemia, granulocyte colony stimulating factor treatment, beta-thalassemia, inflammation and infections. [345678] Splenic uptake, greater than hepatic uptake, is a relatively reliable indicator of lymphomatous involvement of the spleen, in the absence of recent cytokine administration.…”
Section: Discussionmentioning
confidence: 99%
“…[1] Furthermore, it is a sensitive modality for early detection of relapse in asymptomatic patients making surveillance 18 F-FDG PET/CT clinically important. [2] Splenic uptake on 18 F-FDG PET can be due to a wide variety of causes such as lymphoma, anemia, granulocyte colony stimulating factor treatment, beta-thalassemia, inflammation and infections. [345678] Splenic uptake, greater than hepatic uptake, is a relatively reliable indicator of lymphomatous involvement of the spleen, in the absence of recent cytokine administration.…”
Section: Discussionmentioning
confidence: 99%
“…Also false positive interpretations are more likely to occur when the new uptake occurs in supra-diaphragmatic locations than in infra-diaphragmatic locations. [14]…”
Section: Methodsmentioning
confidence: 99%